Nom du produit:Propanedioic acid, 2-(4-bromophenyl)-, 1,3-dimethyl ester

IUPAC Name:1,3-dimethyl 2-(4-bromophenyl)propanedioate

CAS:149506-35-4
Formule moléculaire:C11H11BrO4
Pureté:95%+
Numéro de catalogue:CM427980
Poids moléculaire:287.11

Unité d'emballage Stock disponible Prix($) Quantité
CM427980-1g in stock ŗŗŗ
CM427980-5g in stock ŹǤŗ
CM427980-25g in stock ʼnƓů

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:149506-35-4
Formule moléculaire:C11H11BrO4
Point de fusion:-
Code SMILES:COC(=O)C(C(=O)OC)C1=CC=C(Br)C=C1
Densité:
Numéro de catalogue:CM427980
Poids moléculaire:287.11
Point d'ébullition:
N° Mdl:MFCD06204131
Stockage:

Column Infos

Aprocitentan
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023.
Aprocitentan is an investigational, novel, oral, dual endothelin receptor antagonist (ERA), which potently inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan has a low potential for drug-drug interaction and a mechanism of action that is ideally suited for the pathophysiology of resistant hypertension.
A new drug application (NDA) for aprocitentan was accepted for review by the US FDA.